# EDGAR Filing Document

**Accession Number:** 0000093314
**File Stem:** 0001477932-25-004973
**Filing Date:** 2025-7
**Character Count:** 2840
**Document Hash:** 3eb7cf99c5e15b07ac04d8978eba53ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-004973.hdr.sgml**: 20250811

**ACCESSION NUMBER**: 0001477932-25-004973

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250710

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VOLITIONRX LTD
- **CENTRAL INDEX KEY:** 0000093314
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 911949078
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1489 WEST WARM SPRINGS ROAD
- **STREET 2:** SUITE 110
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89014
- **BUSINESS PHONE:** 1 (646) 650-1351

**MAIL ADDRESS:**
- **STREET 1:** 1489 WEST WARM SPRINGS ROAD
- **STREET 2:** SUITE 110
- **CITY:** HENDERSON
- **STATE:** NV
- **ZIP:** 89014

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STANDARD CAPITAL CORP
- **DATE OF NAME CHANGE:** 19990812

**VOLITIONRX LIMITED**

1489 West Warm Springs Road, Suite 110

Henderson, Nevada 89014

July 10, 2025

**SUBMITTED VIA EDGAR**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Joshua Gorsky

---

| | |
|:---|:---|
| **Re:** | **VolitionRx Limited's Acceleration Request** |
|  | **Registration Statement on Form S-3** |
|  | **Filed July 3, 2025** |
|  | **File No. 333- 288508** |
| **Requested Date**: July 14, 2025<br> **Requested Time**: 5:00 P.M. Eastern Time | **Requested Date**: July 14, 2025<br> **Requested Time**: 5:00 P.M. Eastern Time |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the "***Company***"), hereby respectfully requests that the Securities and Exchange Commission (the "***Commission***") takes appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the "Requested Date" and "Requested Time" set forth above, or as soon thereafter as practicable.

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company's outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com. We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective.

---

| |
|:---|
| Sincerely,<br>VOLITIONRX LIMITED |
| */s/ Cameron Reynolds* |
| Cameron Reynolds<br> President and Chief Executive Officer |

---

cc:

**VolitionRx Limited**

Terig Hughes, Chief Financial Officer

**Stradling Yocca Carlson & Rauth LLP**

Marc G. Alcser, Esq.